In selected cases, short-term reintroduction of low-dose GLP-1 support may be considered as part of a structured long-term strategy rather than continuous treatment
Despite FDA bans on off-label claims, direct-to-consumer ads spent $809M in 2023 promoting Ozempic, Wegovy, Mounjaro and Rybelsus
Wat is BPC-157
This guide explains what each peptide does, why the combination works better than either alone, what patients realistically see from treatment, and who is a suitable candidate
Tirzepatide causes nausea in approximately 25-33% of users depending on dose, compared to 44% for semaglutide at 2.4 mg
PG: Conceptualization, Project administration, Supervision, Validation, Writing review & editing